1-(Pyridin-3-yl)piperazine dihydrochloride, 95.0%, 500mg

2-Bromo-5-chlorothiazole, 95.0%, 25g

3,4-Dichloro-2-fluorobenzoic acid, 97%, 500mg

(S)-tert-Butyl 3-(cyanomethyl)pyrrolidine-1-carboxylate, 95.0%, 250mg

3-(2-Hydroxyphenyl)-1H-pyrazole-5-carboxylic acid hydrate, 95.0%, 1g

4-tert-Butyl-o-xylene>98.0%(GC)25g

N,N'-Bis(tert-butoxycarbonyl)-S-methylisothiourea>98.0%(HPLC)(N)5g

Mandelic acid 3,3,5-trimethylcyclohexyl ester, 94.0%, 250g

(4R,4'S)-4,4'-Di-tert-butyl-1,1'-bis(3-(tert-butyl)phenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

Methyl 4-amino-5-iodo-2-methoxybenzoate, 95.0%, 250mg

4-HYDROXYPHENYLGLYOXYLIC ACID, 95.0%, 250mg

Cloruro de litio, mínimo 99 %, pa, ACS, 500 g, envase de plástico.

2,3-Dibromo-6-hydroxy-5-methoxy-benzaldehyde, 1g